Company attributes
Location
B2X
CEO
Founder
Pitchbook URL
Legal Name
Emendo Therapeutics, Inc.
Parent Organization
Legal classification
Number of Employees (Ranges)
51 – 200
Email Address
info@emendobio.com0
Phone Number
+191767555850
Full Address
400 W 61st St, New York, NY, 100690
Investors
Founded Date
May 1, 2015
Total Funding Amount (USD)
61,000,000
Latest Funding Round Date
January 15, 2020
Latest Funding Type
Motto/Tagline
Making any gene targetable
Technologies Used
Country
Headquarters
Other attributes
Company Operating Status
Active
Emendo Biotherapeutics is a company that is focused on creating cures for untreatable diseases. It is an American company founded by Shilo Ben Zeev in 2015. The company works on using protein engineering structures to edit genes, repair DNA, and create medicine for rare disorders. It is headquartered in New York.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
